Exosome-mediated inhibition of microRNA-449a promotes the amplification of mouse retinal progenitor cells and enhances their transplantation in retinal degeneration mouse models

Jing Han,Hong Yan,Hua Han,Chen jun Guo,Xiu li Cao,Yu fei Zhang,Kang yi Yue,Min hua Zheng

DOI: https://doi.org/10.1016/j.omtn.2023.02.015

2023-02-18

Abstract:Inherited and age-related retinal degenerations are commonest causes of blindness without effective treatments. Retinal progenitor cells (RPCs), which hold the multipotency to differentiate into various retinal cell types, are regarded as a promising source of cell transplantation therapy for retinal degenerative diseases. However, the self-limited expansion of RPCs causes difficulty in cell source supply and restrict its clinical treatment. In this work, we found that inhibition of miR-449a in RPCs can promote proliferation and inhibit apoptosis of RPCs, partially through upregulating Notch signaling. And further optimization of transduction miR-449a inhibitor into RPCs by endothelial cell-derived exosomes can promote the survival of RPCs transplanted in vivo and reduce cell apoptosis in retinal degeneration mouse models. In summary, these studies have shown that exosome-miR-449a inhibitor can effectively promote the expansion of RPCs in vitro , and enhance transplanted RPCs survival in vivo , which might provide novel intervention strategy for retinal degenerations in the future.

medicine, research & experimental